Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

'New era of growth': AstraZeneca sets out bold plans for $80bn revenues by 2030

The growth will be fuelled by 20 new drugs that are set to launch this decade

Evening Standard

Why Dyne Therapeutics, With A 166% Run This Year, Just Catapulted Again

Top-notch biotech stock Dyne broke out Monday after the company unveiled promising test results for a pair of muscular dystrophy drugs.

Investors Business Daily

3 Biotech Stocks Poised for May Surges

The use of advanced technologies, growing demand for personalized medicines, and rising investments in R&D are boosting the biotech industry’s prospects. Given this backdrop, investors could consider buying quality biotech stocks: Amgen (AMGN), Jazz Pharmaceuticals (JAZZ), and ANI Pharmaceuticals (ANIP). Read on.

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Pharma Stocks Primed for May Investment Opportunities

The pharma industry is poised for tremendous growth driven by surging healthcare needs, the introduction of groundbreaking medications, and relentless technological innovation. Hence, quality pharma stocks Collegium Pharmaceutical (COLL), Green Thumb Industries (GTBIF), and Bristol-Myers Squibb (BMY) emerge as prime investment options this month. Read more….

StockNews.com

Imagine getting life-saving drugs to sick people without relying on big pharma? We may have found a way

An NHS trust’s attempts to bring a crucial drug to market itself is hopeful news for patients, says Dr Catriona Crombie of the medical charity LifeArc

The Guardian - UK

3 Pharma Stocks to Buy for Potential Financial Fortunes

Amid surging medicine demand and ongoing drug shortages, the pharmaceutical industry thrives, driving improved patient outcomes and promising growth opportunities for investors. So, it could be wise to invest in quality pharma stocks ACADIA Pharmaceuticals (ACAD), Neurocrine Biosciences (NBIX), and Supernus Pharmaceuticals (SUPN), which can help you fetch potential financial…

StockNews.com

Biogen Stock Continues Its 24% Sprint On A Twist In Alzheimer's Treatment

Biogen stock jumped Wednesday after the FDA gave its Eisai-partnered Alzheimer's treatment a fast track designation.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

3 Top-Rated Pharma Stocks to Diversify Your Portfolio

The pharmaceutical industry is expanding owing to the rising incidence of chronic diseases, increasing investments in R&D, and the use of advanced technologies for drug development and manufacturing. Given this backdrop, investors could consider buying quality pharma stocks such as Elanco Animal Health (ELAN), Viatris (VTRS), and Astellas Pharma (ALPMY),…

StockNews.com

AstraZeneca’s Covid vaccine is no more – but its remarkable success must not be forgotten

Although dogged by controversy, the firm’s coronavirus jab saved the lives of millions and helped avert humanitarian crises in nations unable to access costly alternatives

The Guardian - UK

Punjab Police busts inter-state illegal pharma supply and manufacturing network

Punjab Police busted an inter-state illegal pharmaceutical supply and manufacturing network operating from a pharma factory in Himachal Pradesh. Read further on Dynamite News:

Dynamite News

Catalyst's New CEO Has Big Ideas For The Small Biotech

Richard Daly has watched Catalyst Pharmaceuticals transform. Now, as the company's new CEO, he has some metamorphic ideas of his own.

Investors Business Daily

Nvidia Leads Five Stocks Near Buy Points As Market Rally Picks Up Steam

Nvidia stock along with four other leading stocks are in or near buy areas as the market rally appears to be picking up steam.

Investors Business Daily

A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation

As the earnings season moves into final innings, some fast-moving names led by Disney, Ferrari and Constellation are due to report.

Investors Business Daily

Buy Alert: 3 Pharma Stocks Under $20 to Invest in Now

With rising medicine demand and drug shortages in the U.S., pharmaceutical stocks under $20 present lucrative opportunities for investors, promising substantial returns in a ripe market. So, I think fundamentally solid pharma stocks ACADIA Pharmaceuticals (ACAD), Amneal Pharmaceuticals (AMRX), and OptiNose (OPTN), which are currently trading under $20, could be…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times

Weight-loss Drug Maker Novo Nordisk's Profits Soar Further

The drugmaker increased its market share of the diabetic treatment market by 1.8 percentage points and now has a 34-percent share of the market.

Evening Standard

How much have NHS prescriptions increased to and who doesn't have to pay?

Pharmacists are concerned the recent rise in the cost of NHS drugs will mean more people won’t be able to afford all the medication they need

StockNews.com

3 Top Pharma Stocks for May 2024

The pharmaceutical sector is experiencing rapid growth, driven by the ever-rising healthcare needs and the adoption of advanced technologies. Against this backdrop, fundamentally strong pharmaceutical stocks such as Teva Pharmaceutical Industries (TEVA), Neurocrine Biosciences (NBIX), and GSK plc (GSK) could be solid portfolio additions for May. Read on.

Investors Business Daily

AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales

Fears that Humira biosimilars will erode AbbVie's topline are overblown, an analyst said Monday. He has an outperform rating on AbbVie stock.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Deciphera Catapults 73% On Ono Pharmaceutical's $2.4 Billion Takeover

Deciphera stock rocketed to a three-year high Monday after Ono Pharmaceutical agreed to buy it for $2.4 billion.

The Guardian - UK

Revealed: UK government was warned of infected blood risks in 1970s

Documents show officials were told blood plasma harvested from US convicts was contaminated with viruses

The Guardian - UK

‘Plasma was called liquid gold’: the true story of the UK infected blood scandal

Documents examined by inquiry show officials knew people were being given infected blood products, but sanctioned their use

Investors Business Daily

How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed

ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.

Investors Business Daily

Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure

The FDA approved Pfizer's hemophilia gene therapy on Friday. But Pfizer stock only inched ahead on the approval early Friday.

Investors Business Daily

Gilead Gives Up Big Gains As Covid Drug Drives Its Beat — Again

Gilead stock pared its gains Friday after beating first-quarter sales forecasts on the back of its Covid treatment, Veklury.

Investors Business Daily

Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market

Novartis paved the way for radiopharmaceuticals. Now, Big Pharma thinks it can do better — and biotech stocks have soared on a spate of deals.

1 … 11 12 13 14

People

Margaret Kaczor Andrew

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.